Abstract Details
|
Eliza M. Gordon-Lipkin, MD
(Kennedy Krieger Institute)
PRESENTER |
No disclosure on file |
| Anusha Yeshokumar, MD (Icahn School of Medicine at Mount Sinai) | Dr. Yeshokumar has nothing to disclose. |
| Ana Arenivas, PhD (Kennedy Krieger Institute) | No disclosure on file |
| Deanna Saylor, MD, MHS, FÂ鶹´«Ã½Ó³» (Johns Hopkins Hospital) | Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³». The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from Â鶹´«Ã½Ó³». Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and Â鶹´«Ã½Ó³»al Innovation Commitees with American Neurological Association that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| John Probasco, MD, FÂ鶹´«Ã½Ó³» (The Johns Hopkins Hospital) | Dr. Probasco has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Clinician. The institution of Dr. Probasco has received research support from Roche/Genentech. |